Page 68 - Cardiac abnormalities after aneurysmal subarachnoid hemorrhage

Chapter 4
17. Zaroff JG, Rordorf GA, Titus JS, Newell JB, Nowak NJ, Torchiana DF, Aretz HT, Picard MH, Macdonald RL. Regional myocardial perfusion after experimental subarachnoid hemorrhage. Stroke 2000 May;31(5):1136-1143.
18. Samuels MA. Neurogenic heart disease: a unifying hypothesis. Am J Cardiol 1987 December 28;60(18):15J-19J.
19. Banki NM, Kopelnik A, Dae MW, Miss J, Tung P, Lawton MT, Drew BJ, Foster E, smith w, Parmley WW, Zaroff JG. Acute neurocardiogenic injury after subarachnoid hemorrhage. Circulation 2005 November 22;112(21):3314-3319.
20. Kothavale A, Banki NM, Kopelnik A, Yarlagadda S, Lawton MT, Ko N, Smith WS, Drew B, Foster E, Zaroff JG. Predictors of left ventricular regional wall motion abnormalities after subarachnoid hemorrhage. Neurocrit Care 2006;4(3):199-205.
21. Tung PP, Olmsted E, Kopelnik A, Banki NM, Drew BJ, Ko N, Lawton MT, smith w, Foster E, Young WL, Zaroff JG. Plasma B-type natriuretic peptide levels are associated with early cardiac dysfunction after subarachnoid hemorrhage. Stroke 2005 July;36(7):1567-1569.
22. Hammer GP, du Prel JB, Blettner M. Avoiding bias in observational studies: part 8 in a series of articles on evaluation of scientific publications. Dtsch Arztebl Int 2009 October;106(41):664-668.
23. van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet 2007 January 27;369(9558):306-318.
24. Naidech A, Du Y, Kreiter KT, Parra A, Fitzsimmons BF, Lavine SD, Connolly ES, Mayer SA, Commichau
C. Dobutamine versus milrinone after subarachnoid hemorrhage. Neurosurgery 2005;56(1):21-6l.
25. Busani S, Rinaldi L, Severino C, Cobelli M, Pasetto A, Girardis M. Levosimendan in cardiac failure after
subarachnoid hemorrhage. J Trauma 2010 May;68(5):E108-E110.
26. Wittstein IS. Stress cardiomyopathy: a syndrome of catecholamine-mediated myocardial stunning? Cell
Mol Neurobiol 2012 July;32(5):847-857.
66